has grown to a total of 16 professionals and has spun out over 50 companies based on the university’s research, a number of which have raised substantial amounts of capital, and the university’s licensing income has climbed steadily.
Prior to entering the technology transfer profession, Dr. Stevens worked in the biotechnology industry for nearly 10 years. He was a co-founder of Kytogenics, Inc., of which he is still a director, was co-founder and general manager of Genmap, Inc., and was vice president of business development for BioTechnica International. He started his career with The Procter & Gamble Company, where he held a number of positions in sales, marketing, strategic planning, and acquisitions.
Dr. Stevens publishes and lectures frequently on many aspects of technology transfer, including the Bayh-Dole Act, the economic impact of technology transfer and its role in economic development, the contribution of academia to the discovery of new drugs and vaccines, and the role of technology transfer in global health and technology valuation. He was the recipient of the Bayh-Dole Award at the Association of University Technology Managers’ (AUTM’s) 2007 Annual Meeting and was recently elected president-elect of AUTM. He will become president of AUTM in March 2010. He is also active in the Licensing Executives Society and the Massachusetts Biotechnology Council.
Dr. Stevens holds a B.A. in natural sciences and an M.A. and a D.Phil. in physical chemistry from Oxford University. He is a Certified Licensing Professional.
Charles Wessner is a National Academy Scholar and director of the Program on Technology, Innovation, and Entrepreneurship. He is recognized nationally and internationally for his expertise on innovation policy, including public-private partnerships, entrepreneurship, early-stage financing for new firms, and the special needs and benefits of high-technology industry. He testifies to the U.S. Congress and major national commissions, advises agencies of the U.S. government and international organizations, and lectures at major universities in the United States and abroad. Reflecting the strong global interest in innovation, he is frequently asked to address issues of shared policy interest with foreign governments, universities, research institutes, and international organizations, often briefing government ministers and senior officials. He has a strong commitment to international cooperation, reflected in his work with a wide variety of countries around the world.
Dr. Wessner’s work addresses the linkages between science-based economic growth, entrepreneurship, new technology development, university-industry clusters, regional development, small-firm finance and public-private partnerships. His program at the National Academies also addresses policy issues associated with international technology cooperation, investment, and trade in high-technology industries.